We represented Luminex Corporation in its acquisition of privately held EraGen Biosciences, Inc. an innovator in molecular diagnostic testing techniques for infectious disease and genetic applications. The acquisition was valued at $34 million.

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.